The CEOs, presidents, and executive management teams of some of the industry’s top publicly traded pharmaceutical and biotechnology companies share their vision and strategies for meeting the
challenges of business in the coming years.
David E.I. Pyott, CBE, Chairman of the Board and CEO, Allergan Inc.
Masafumi Nogimori, President and CEO, Astellas
Lamberto Andreotti, CEO, Bristol-Myers Squibb
Joe Jimenez, CEO, Novartis AG
Yasuchika Hasegawa, President and CEO, Takeda